Effects of exercise training on circulating and skeletal muscle renin-angiotensin system in chronic heart failure rats

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Gomes Santos, Igor Lucas ^a   Fernandes, Tiago ^a   Couto, Gisele Kruger ^a   Ferreira Filho, Julio César Ayres ^a   Salemi, Vera Maria Cury ^a   Fernandes, Fernanda Barrinha ^b   Casarini, Dulce Elena ^b   Brum, Patricia Chakur ^a   Rossoni, Luciana Venturini ^a   De Oliveira, Edilamar Menezes ^a   Negrao, Carlos Eduardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN[1-7]; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AT1 GENE; AT2 GENE; CORONARY ARTERY LIGATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXERCISE; GENE; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; INFANT; LEFT CORONARY ARTERY; MALE; MAS RECEPTOR GENE; MUSCLE BLOOD FLOW; NONHUMAN; PLANTARIS MUSCLE; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEDENTARY LIFESTYLE; SHAM PROCEDURE; SKELETAL MUSCLE; SOLEUS MUSCLE; ANIMAL; BLOOD; HEART FUNCTION TEST; METABOLISM; PATHOPHYSIOLOGY; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; HEART FAILURE; HEART FUNCTION TESTS; MALE; MUSCLE, SKELETAL; PEPTIDYL-DIPEPTIDASE A; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM;

EID: 84901462181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098012     Document Type: Article

References (51)

1. Sigurdsson A, Held P, Swedberg K. (1993) Short- and long-term neurohormonal activation following acute myocardial infarction. Am Heart J 126: 1068-1076. (Pubitemid 23330405)
2. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. (1985) Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72: 406-412. (Pubitemid 15019891)
3. Kato M, Kinugawa T, Omodani H, Osaki S, Ahmmed GU, et al. (1996) Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure. J Card Fail 2: 103-110. (Pubitemid 126666359)
4. Roig E, Perez-Villa F, Morales M, Jiménez W, Orús J, et al. (2000) Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. Eur Heart J 21: 53-57. (Pubitemid 30042669)
5. Xu X, Wan W, Ji L, Lao S, Powers AS, et al. (2008) Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats. Cardiovasc Res 78: 523-532. (Pubitemid 351769760)
6. Ferreira JCB, Bacurau A V, Evangelista FS, Coelho MA, Oliveira EM, et al. (2008) The role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Am J Physiol Regul Integr Comp Physiol 294: R26-32.
7. Kar S, Gao L, Zucker IH. (2010) Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure. J Appl Physiol 108: 923-932.
8. Schunkert H, Ingelfinger JR, Hirsch a T, Tang SS, Litwin SE, et al. (1992) Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest 90: 1523-1529.
9. Pfeffer JM, Pfeffer MA, Braunwald E. (1985) Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57: 84-95. (Pubitemid 15238844)
10. Mousa TM, Liu D, Cornish KG, Zucker IH. (2008) Exercise training enhances baroreflex sensitivity by an angiotensin II-dependent mechanism in chronic heart failure. J Appl Physiol 5850: 616-624. (Pubitemid 351468788)
11. Abassi ZA, Gurbanov K, Mulroney SE, Potlog C, Opgenorth TJ, et al. (1997) Impaired nitric oxide-mediated renal vasodilation in rats with experimental heart failure: role of angiotensin II. Circulation 96: 3655-3664. (Pubitemid 27513446)
12. Dalla Libera L, Ravara B, Angelini A, Rossini K, Sandri M, et al. (2001) Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. Circulation 103: 2195-2200. (Pubitemid 32458329)
13. Russell ST, Eley H, Tisdale MJ. (2007) Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II. Cell Signal 19: 1797-1806. (Pubitemid 46935435)
14. Semprun-Prieto LC, Sukhanov S, Yoshida T, Rezk BM, Gonzalez-Villalobos RA, et al. (2011) Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. Biochem Biophys Res Commun 409: 217-221.
15. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, et al. (2000) A Novel Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9. Circ Res 87: e1-e9.
16. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, et al. (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243.
17. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, et al. (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277: 14838-14843. (Pubitemid 34952556)
18. Santos RAS, Simoes e Silva AC, Maric C, Silva DMR, Machado RP, et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100: 8258-8263. (Pubitemid 36842532)
19. Prasannarong M, Santos FR, Henriksen EJ. (2012) Ang-(1-7) reduces Ang II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle. Biochem Biophys Res Commun 426: 369-373.
20. Muñoz MC, Giani JF, Burghi V, Mayer MA, Carranza A, et al. (2012) The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7). Regul Pept 177: 1-11.
21. Santos RAS, Ferreira AJ, Verano-Braga T, Bader M. (2013) Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the reninangiotensin system. J Endocrinol 216: R1-R17.
22. Negrao CE, Middlekauff HR (2008) Adaptations in autonomic function during exercise training in heart failure. Heart Fail Rev 13: 51-60. (Pubitemid 350278733)
23. Roveda F, Middlekauff HR, Rondon MU, Reis SF, Souza M, et al. (2003) The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. J Am Coll Cardiol 42: 854-860. (Pubitemid 37059744)
24. De Mello Franco FG, Santos AC, Rondon MUP, Trombetta IC, Strunz C, et al. (2006) Effects of home-based exercise training on neurovascular control in patients with heart failure. Eur J Heart Fail 8: 851-855. (Pubitemid 44779414)
25. Braith RW, Welsch MA, Feigenbaum MS, Kluess HA, Pepine CJ. (1999) Neuroendocrine activation in heart failure is modified by endurance exercise training. J Am Coll Cardiol 34: 1170-1175. (Pubitemid 29500556)
26. Fernandes T, Hashimoto NY, Magalhães FC, Fernandes FB, Casarini DE, et al. (2011) Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7). Hypertension 58: 182-189.
27. Filho AG, Ferreira AJ, Santos SHS, Neves SRS, Silva Camargos ER, et al. (2008) Selective increase of angiotensin(1-7) and its receptor in hearts of spontaneously hypertensive rats subjected to physical training. Exp Physiol 93: 589-598. (Pubitemid 351595056)
28. Gao E, Lei YH, Shang X, Huang ZM, Zuo L, et al. (2010) A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 107: 1445-1453.
29. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiograph. J Am Soc Echocardiogr 18: 1440-1463. (Pubitemid 41821197)
30. Brooks GA, White TP (1978) Determination of metabolic and heart rate responses of rats to treadmill exercise. J Appl Physiol 45: 1009-1015. (Pubitemid 9211572)
31. Rondon E, Brasileiro-Santos MS, Moreira ED, Rondon MUPB, Mattos KC, et al. (2006) Exercise training improves aortic depressor nerve sensitivity in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol 291: H2801-6. (Pubitemid 44904080)
32. Fernandes T, Hashimoto NY, Oliveira EM. (2010) Characterization of angiotensin-converting enzymes 1 and 2 in the soleus and plantaris muscles of rats. Braz J Med Biol Res 43: 837-842.
33. Liu JL, Irvine S, Reid IA, Patel KP, Zucker IH. (2000) Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure: A role for angiotensin II. Circulation 102: 1854-1862.
34. Barretto ACP, Santos AC, Munhoz R, Rondon MU, Franco FG, et al. (2009) Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int J Cardiol 135: 302-307.
35. Osterziel KJ, Hänlein D, Willenbrock R, Eichhorn C, Luft F, et al. (1995) Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. Br Heart J 73: 517-522.
36. Epelman S, Tang WH, Chen SY, Van Lente F, Francis GS, et al. (2008) Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin- aldosterone system. J Am Coll Cardiol 52: 750-754.
37. Patel VB, Clarke N, Wang Z, Fan D, Parajuli N, et al. (2014) Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS. J Mol Cell Cardiol 66: 167-176.
38. Ocaranza MP, Godoy I, Jalil JE, Varas M, Collantes P, et al. (2006) Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension 48: 572-578. (Pubitemid 44843858)
39. Agata J, Ura N, Yoshida H, Shinshi Y, Sasaki H, et al. (2006) Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme. Hypertens Res 29: 865-874. (Pubitemid 46062117)
40. Ferrario CM. (2011) ACE2: more of Ang-(1-7) or less Ang II? Curr Opin Nephrol Hypertens 20: 1-6.
41. Mariappan N, Elks CM, Haque M, Francis J. (2012) Interaction of TNF with angiotensin II contributes to mitochondrial oxidative stress and cardiac damage in rats. PLoS One 7: e46568.
42. Vescovo G, Volterrani M, Zennaro R, Sandri M, Ceconi C, et al. (2000) Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 84: 431-437.
43. Burniston JG, Saini A, Tan L-B, Goldspink DF (2005) Angiotensin II induces apoptosis in vivo in skeletal, as well as cardiac, muscle of the rat. Exp Physiol 90: 755-761. (Pubitemid 41406064)
44. Van Kats JP, de Lannoy LM, Jan Danser AH, van Meegen JR, Verdouw PD, et al. (1997) Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension 30: 42-49. (Pubitemid 27306345)
45. Uehara Y, Miura S, Yahiro E, Saku K. (2013) Non-ACE pathway-induced angiotensin II production. Curr Pharm Des 19: 3054-3059.
46. Akasu M, Urata H, Kinoshita A, Sasaguri M, Ideishi M, et al. (1998) Differences in tissue angiotensin II-forming pathways by species and organs in vitro. Hypertension 32: 514-520. (Pubitemid 28429142)
47. Ward PE, Russell JS, Vaghy PL. (1995) Angiotensin and bradykinin metabolism by peptidases identified in skeletal muscle. Peptides 16: 1073-1078.
48. Johnston APW, Baker J, De Lisio M, Parise G. (2011) Skeletal muscle myoblasts possess a stretch-responsive local angiotensin signalling system. J Renin Angiotensin Aldosterone Syst 12: 75-84.
49. Dimitrijevic I, Edvinsson M-L, Chen Q, Malmsjö M, Kimblad P-O, et al. (2009) Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease. BMC Cardiovasc Disord 9: 40.
50. Zhang G-X, Ohmori K, Nagai Y, Fujisawa Y, Nishiyama A, et al. (2007) Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice. J Mol Cell Cardiol 42: 804-811. (Pubitemid 46527601)
51. Malendowicz SL, Ennezat P V, Testa M, Murray L, Sonnenblick EH, et al. (2000) Angiotensin II receptor subtypes in the skeletal muscle vasculature of patients with severe congestive heart failure. Circulation 102: 2210-2213.